COMMENT
Is there too much euphoria over the potential vaccines? Market was already in a transition away from momentum stocks. Starting to move into value. The Pfizer announcement created a big jump in stocks that were already starting to move. Stocks aren't necessarily too much ahead of themselves, but we're going to have a rough patch or two before it's all done.
COMMENT
Longer term, sobering thoughts on US debt to GDP? The long downtrend of US GDP dropped in 2008 to less than $3 of debt to $1 of GDP for the first time, and we had the worst recession since the Great Depression. It held tight at the 3.5:1 ratio until we got to 2020. Now we're back in the same condition as 2008, and along came Covid. GDP plunged as indebtedness went up. Can't tell if it's a Covid effect or something else. The economy won't bounce back in 2021 the way people are expecting. Covid isn't over yet, despite the vaccines.
HOLD

Fell to book value, but jumped on Pfizer announcement. Intrinsic value is 60% higher than current value. Fairly indifferent balance sheet. If it can break above $31, could easily go as high as $42. No yield.

COMMENT
Time to take profits from gold and silver? No. Outlook for inflation is perking up. Historically, upwards pressure on interest rates plus upwards pressure on commodity prices. Stay the course in the golds, and add some of the other commodities including copper. Not the time to bail, just because they're in a temporary hiatus.
SELL
It's been buying back stock, so they don't have any book value. This is not a solid mattress to lie on. Fair market value is about 53% lower than the current price. If we're shifting away from growth to value, this isn't the one to buy.
SELL
It's hanging in, but it's been buying back stock and keeping upwards pressure on the price. Not cheap. FANGs in general are rolling over. Same as rollovers of the Nifty Fifty in 1972 and the dot.coms of 2000. Be cautious of this group in general.
HOLD

Trades at 2.5x book, versus Netflix at 20x book. DIS has moved ahead slowly like a value stock, whereas Netflix is having trouble and rolling over. We still haven't seen DIS earnings from streaming. Stock is 57% overvalued. Stock technically broke out. Hang in there, albeit nervously.

RISKY
Can't find all that much wrong, or right, with the stock. Price to book is 8x, so not cheap. Reasonable value for a hypergrowth stock, as it's only 18% overvalued. Technically, $17-17.50 should hold. At that level, could be looking at a nice trade.
HOLD
Concerned about the dividend. In the midst of expansion. Need all the market goodwill they can get, so probably won't cut the dividend. Technically, back to good support. Nervously hang in there.
WAIT
Looks as though it's heading lower. His downside target is $50. When it got there in June, had a nice rebound. Hang on, and add at those levels. In 2021, US deficit is going to be something else, and Fed will have to bail them out. More stimulus is good for gold.
DON'T BUY
A falling knife. Earnings forecast scheduled to fall year over year. Price to book is 9x, intrinsic value is 80% below current price. Technical failure at $185 down to $143. ROE is only 8.7%.
PAST TOP PICK
(A Top Pick Dec 04/19, Up 13%) He'd buy it again. Nice value stock. Nice yield. Trading at discount to book. Would benefit from rising interest rates, which he expects. Cheaper than all the banks.
PAST TOP PICK
(A Top Pick Dec 04/19, Down 10%) All financials got hammered in Covid meltdown. Earnings and FMV held in as the stock price collapsed. Now seeing a strong recovery and should go quite a bit further.
PAST TOP PICK
(A Top Pick Dec 04/19, Down 6%) Problems bringing new mine on. Earnings forecasts going up sharply. Upside potential as measured by analysts is quite high. Trading at 40% discount to book value.
BUY
He'd buy at current price. Since July, trading in a fairly wide range. Earnings forecasts rocketing straight upwards. Not surprised if it bursts through top of range, $10.80. FMV currently 108x existing price.